Pharmacology · Cytotoxic and Targeted Therapy (Monoclonal Antibodies)

Haemorrhagic cystitis occurring after high-dose cyclophosphamide is caused by a metabolite excreted in urine. The metabolite and the protective agent are:

  • A Acrolein and allopurinol
  • B Chloroacetaldehyde and amifostine
  • C Phosphoramide mustard and leucovorin
  • D Acrolein and mesna
Correct answer: D. Acrolein and mesna

Explanation

Acrolein, a byproduct of hepatic metabolism of cyclophosphamide, is excreted in urine and directly irritates urothelium, causing haemorrhagic cystitis. Mesna is a sulfhydryl compound that binds acrolein in the bladder and detoxifies it, and is given with high-dose regimens along with vigorous hydration. Phosphoramide mustard is the alkylating antitumour metabolite, not the urotoxin. Allopurinol prevents urate nephropathy in tumour lysis, not cystitis.

Reference: Katzung's Basic and Clinical Pharmacology, 16th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Cytotoxic and Targeted Therapy (Monoclonal Antibodies) MCQs

See all Cytotoxic and Targeted Therapy (Monoclonal Antibodies) MCQs →